BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu G, Zhu H, Zhang M, Xu J. Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5. Int J Mol Med 2018;41:155-63. [PMID: 29115379 DOI: 10.3892/ijmm.2017.3225] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Tonmoy MIQ, Fariha A, Hami I, Kar K, Reza HA, Bahadur NM, Hossain MS. Computational epigenetic landscape analysis reveals association of CACNA1G-AS1, F11-AS1, NNT-AS1, and MSC-AS1 lncRNAs in prostate cancer progression through aberrant methylation. Sci Rep 2022;12:10260. [PMID: 35715447 DOI: 10.1038/s41598-022-13381-0] [Reference Citation Analysis]
2 Rahbari R, Rasmi Y, Khadem-Ansari MH, Abdi M. The role of histone deacetylase 3 in breast cancer. Med Oncol 2022;39:84. [PMID: 35578147 DOI: 10.1007/s12032-022-01681-4] [Reference Citation Analysis]
3 Yang Q, Chen Y, Guo R, Dai Y, Tang L, Zhao Y, Wu X, Li M, Du F, Shen J, Yi T, Xiao Z, Wen Q. Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification. Front Oncol 2021;11:822745. [PMID: 35155211 DOI: 10.3389/fonc.2021.822745] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Lou T, Liu C, Qu H, Zhang Z, Wang S, Zhuang H. FOXA1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma. J Transl Med 2022;20:19. [PMID: 34991620 DOI: 10.1186/s12967-021-03224-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu L, Zheng Q. CHD3/4/5/6/8 serve as potential prognostic predictors in human gastric cancer. Netw Model Anal Health Inform Bioinforma 2021;10:34. [DOI: 10.1007/s13721-021-00307-5] [Reference Citation Analysis]
6 Maralani M, Shanehbandi D, Asadi M, Hashemzadeh S, Hajiasgharzadeh K, Mashhadi Abdolahi H, Baradaran B, Peeters M. Expression profiles of miR-196, miR-132, miR-146a, and miR-134 in human colorectal cancer tissues in accordance with their clinical significance : Comparison regarding KRAS mutation. Wien Klin Wochenschr 2021. [PMID: 34463887 DOI: 10.1007/s00508-021-01933-9] [Reference Citation Analysis]
7 Liu X, Ma R, Yi B, Riker AI, Xi Y. MicroRNAs are involved in the development and progression of gastric cancer. Acta Pharmacol Sin 2021;42:1018-26. [PMID: 33037405 DOI: 10.1038/s41401-020-00540-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
8 Adhikari N, Jha T, Ghosh B. Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy. J Med Chem 2021;64:8827-69. [PMID: 34161101 DOI: 10.1021/acs.jmedchem.0c01676] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
9 Harachi M, Masui K, Cavenee WK, Mischel PS, Shibata N. Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer. Metabolites 2021;11:216. [PMID: 33916219 DOI: 10.3390/metabo11040216] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
10 Wu M, Jiang M, Xue M, Li Q, Cheng B, Huang M, Xu L, Zhang Y. [Epigallocatechin gallate induces CHD5 gene demethylation to promote acute myeloid leukemia cell apoptosis in vitro by regulating p19Arf-p53-p21Cip1 signaling pathway]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1230-8. [PMID: 32990229 DOI: 10.12122/j.issn.1673-4254.2020.09.02] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Vitale AM, Santonocito R, Vergilio G, Marino Gammazza A, Campanella C, Conway de Macario E, Bucchieri F, Macario AJL, Caruso Bavisotto C. Brain Tumor-Derived Extracellular Vesicles as Carriers of Disease Markers: Molecular Chaperones and MicroRNAs. Applied Sciences 2020;10:6961. [DOI: 10.3390/app10196961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
12 Yang Z, Jiang X, Zhang Z, Zhao Z, Xing W, Liu Y, Jiang X, Zhao H. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer. Cancer Gene Ther 2021;28:141-55. [PMID: 32655129 DOI: 10.1038/s41417-020-0193-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
13 Li H, Li H, Waresijiang Y, Chen Y, Li Y, Yu L, Li Y, Liu L. Clinical significance of HDAC1, -2 and -3 expression levels in esophageal squamous cell carcinoma. Exp Ther Med 2020;20:315-24. [PMID: 32536999 DOI: 10.3892/etm.2020.8697] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Huang C, Liu J, Pan X, Peng C, Xiong B, Feng M, Yang X. miR-454 promotes survival and induces oxaliplatin resistance in gastric carcinoma cells by targeting CYLD.Exp Ther Med. 2020;19:3604-3610. [PMID: 32346424 DOI: 10.3892/etm.2020.8655] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 徐 珊. The Relationship between Histone Deacetylase (HDACs) and Gastric Cancer. ACM 2020;10:2127-2132. [DOI: 10.12677/acm.2020.109320] [Reference Citation Analysis]
16 Hashimoto T, Kurokawa Y, Wada N, Takahashi T, Miyazaki Y, Tanaka K, Makino T, Yamasaki M, Nakajima K, Mori M, Doki Y. Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancer. Oncol Lett 2020;19:1066-73. [PMID: 31897220 DOI: 10.3892/ol.2019.11138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Qiu Z, Wang L, Mao H, Xu F, Sun B, Lian X, Wang J, Kong F, Wang L, Chen Y. miR-370 inhibits the oxidative stress and apoptosis of cardiac myocytes induced by hydrogen peroxide by targeting FOXO1. Exp Ther Med 2019;18:3025-31. [PMID: 31555385 DOI: 10.3892/etm.2019.7908] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
18 Xiao Q, Chen L, Luo H, Li H, Kong Q, Jiao F, Pang S, Zhang M, Lan F, Fan W, Luo H, Tao T, Zhu X. A rare CHD5 haplotype and its interactions with environmental factors predicting hepatocellular carcinoma risk. BMC Cancer 2018;18:658. [PMID: 29907144 DOI: 10.1186/s12885-018-4551-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
19 Bao M, Song Y, Xia J, Li P, Liu Q, Wan Z. miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer. Onco Targets Ther 2018;11:1721-32. [PMID: 29618932 DOI: 10.2147/OTT.S157715] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
20 Liu X, Tong Z, Chen K, Hu X, Jin H, Hou M. The Role of miRNA-132 against Apoptosis and Oxidative Stress in Heart Failure. Biomed Res Int 2018;2018:3452748. [PMID: 29682535 DOI: 10.1155/2018/3452748] [Cited by in Crossref: 10] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]